AMETEK, Inc.

AMETEK, Inc. (AME) Market Cap

AMETEK, Inc. has a market capitalization of $52.79B.

Financials based on reported quarter end 2025-12-31

Price: $230.46

β–Ό -3.08 (-1.32%)

Market Cap: 52.79B

NYSE Β· time unavailable

CEO: David A. Zapico

Sector: Industrials

Industry: Industrial - Machinery

IPO Date: 1984-07-19

Website: https://www.ametek.com

AMETEK, Inc. (AME) - Company Information

Market Cap: 52.79B Β· Sector: Industrials

AMETEK, Inc. manufactures and sells electronic instruments and electromechanical devices worldwide. It operates in two segments, Electronic Instruments (EIG) and Electromechanical (EMG). The company's EIG segment offers advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; and instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets. This segment also provides power quality monitoring and metering devices, uninterruptible power supplies, programmable power equipment, electromagnetic compatibility test equipment, gas turbines, and environmental health and safety market sensors, dashboard instruments for heavy trucks and other vehicles, and instrumentation and controls for the food and beverage industries; and aircraft and engine sensors, monitoring systems, power supplies, fuel and fluid measurement systems, and data acquisition systems for the aerospace industry. Its EMG segment offers engineered electrical connectors and electronics packaging to protect sensitive devices and mission-critical electronics; precision motion control products for data storage, medical devices, business equipment, automation, and other applications; high-purity powdered metals, strips and foils, specialty clad metals, and metal matrix composites; motor-blower systems and heat exchangers for use in thermal management, military, commercial aircraft, and military ground vehicles; and motors for use in commercial appliances, fitness equipment, food and beverage machines, hydraulic pumps, and industrial blowers. This segment also operates a network of aviation maintenance, repair, and overhaul facilities. In addition, the company offers clinical and educational communication solutions. AMETEK, Inc. was founded in 1930 and is headquartered in Berwyn, Pennsylvania.

Analyst Sentiment

73%
Strong Buy

Based on 29 ratings

Analyst 1Y Forecast: $232.50

Average target (based on 4 sources)

Consensus Price Target

Low

$215

Median

$240

High

$271

Average

$243

Potential Upside: 5.3%

Price & Moving Averages

Loading chart...

πŸ“˜ Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

πŸ“˜ AMETEK, Inc. (AME) β€” Investment Overview

🧩 Business Model Overview

AMETEK, Inc. is a diversified manufacturer specializing in electronic instruments and electromechanical devices. The company operates through two principal business segments: Electronic Instruments and Electromechanical products. AMETEK’s core offerings include advanced measurement, monitoring, calibration, and precision control instruments, as well as a range of engineered electromechanical systems. Its products serve a wide array of industries such as aerospace, power generation, medical, industrial automation, and semiconductor manufacturing. The customer base is global and highly diversified, encompassing government agencies, original equipment manufacturers (OEMs), and end users who require high-reliability instrumentation and automation solutions for mission-critical applications.

πŸ’° Revenue Model & Ecosystem

AMETEK derives revenues from a combination of equipment sales, aftermarket services, consumables, and software-based solutions. The primary revenue stream is from the sale of highly engineered physical products, such as analyzers, sensors, motors, and electronic controls. Recurring revenues are supported by proprietary parts, service contracts, calibration services, and ongoing technical support. A growing segment involves software-driven monitoring platforms and data analytics, resulting in embedded value and increased customer dependency. The mix is largely enterprise-focused, serving commercial and industrial accounts, with a smaller share from government or institutional sectors. The company’s broad portfolio enables cross-selling and long-term multi-product relationships.

🧠 Competitive Advantages

  • Brand strength: AMETEK has an established reputation as a provider of high-performance and reliable solutions, trusted across regulated and safety-critical sectors.
  • Switching costs: Proprietary interfaces, certification requirements, and deep integration into client infrastructure make product replacement costly and time-consuming for customers.
  • Ecosystem stickiness: Aftermarket service, calibration, and consumables contribute to recurring relationships and help lock in enterprise accounts.
  • Scale + supply chain leverage: Global manufacturing and sourcing operations allow AMETEK to deliver quality at scale while achieving cost efficiencies and maintaining resilient supply chains.

πŸš€ Growth Drivers Ahead

AMETEK’s long-term growth levers are supported by organic innovation, bolt-on acquisitions, and expanding global infrastructure needs. Technological advances in automation, IoT-enabled devices, and precision analytics drive demand for its core instrumentation offerings. The company remains focused on serving secular growth sectors, including renewable energy, medical devices, and aerospace modernization. Acquisitive expansion into complementary, high-margin niches continues to diversify the business and introduce new technologies. Additionally, increasing emphasis on digitalization and predictive maintenance creates further opportunities for recurring, high-value software and service offerings.

⚠ Risk Factors to Monitor

Investors should remain aware of competitive pressures from both established conglomerates and disruptive new entrants introducing lower-cost alternatives or advanced digital platforms. Margin compression can result from raw material price volatility or aggressive pricing in commoditized segments. Changes in regulatory standards, particularly for products serving aerospace, defense, or medical markets, may necessitate costly redesigns or impact approval cycles. Technological disruption risk exists should AMETEK lag in integrating advanced digital, automation, or cloud-driven capabilities into its portfolio.

πŸ“Š Valuation Perspective

AMETEK is typically valued at a relative premium compared to peers in the diversified industrial and instrumentation space. This valuation reflects the company’s consistent operating execution, high levels of recurring revenue, and defensible business segments with substantial barriers to entry. Market participants often assign AMETEK a favorable status due to its successful track record of profitable growth and prudent capital deployment strategy, especially when compared to less diversified or more cyclical competitors.

πŸ” Investment Takeaway

AMETEK presents a compelling investment proposition for those seeking exposure to high-quality industrial technology names with global reach and recurring revenue dynamics. The bull case centers on the company’s disciplined acquisition model, exposure to secular growth trends, and portfolio of mission-critical instrumentation with entrenched enterprise relationships. The bear case hinges on the potential for technological obsolescence, cyclical exposure in certain end markets, and competitive threats from innovation-driven or lower-cost players. Continued operational excellence and adaptability to shifting technology trends remain key to sustaining long-term shareholder value.


⚠ AI-generated research summary β€” not financial advice. Validate using official filings & independent analysis.

Fundamentals Overview

Loading fundamentals overview...

πŸ“Š AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2025-12-31

"AME reported strong top-line momentum in the latest quarter (2025-12-31). Revenue rose 5.6% QoQ (to $1.999B) and 13.5% YoY (vs. 2024-12-31). Net income increased 7.3% QoQ (to $399M) and 3.0% YoY, but profitability was mixed: net margin improved QoQ (19.9% vs. 19.6%) yet declined vs. last year (19.9% vs. 22.0%). EPS followed the income trend, climbing 8.1% QoQ and 3.6% YoY. Balance sheet quality appears resilient and improving short-term. Total assets increased YoY (+9.9%) and equity also grew (+10.1%), indicating solid capital base expansion. Net debt decreased meaningfully QoQ (about -20.9%), which supports financial flexibility, though leverage remains a consideration given the absolute net debt level. Shareholder returns have been a key driver: the stock is up 49.0% over the last 1 year (>20% momentum), which should materially boost total return despite a low dividend yield (~0.15%). With consensus valuation targets around $240–$243 versus the current ~$236, upside from price targets looks modest, while the valuation (P/E ~29.6) implies investors are paying for continued execution."

Revenue Growth

Good

Revenue grew 5.6% QoQ and 13.5% YoY, showing an accelerating run-rate versus last year.

Profitability

Neutral

Net income rose 7.3% QoQ and 3.0% YoY, but net margin contracted vs. YoY (about 19.9% vs. 22.0%), indicating some profitability pressure despite improved quarter-over-quarter margins.

Cash Flow Quality

Neutral

Dividends appear well covered by earnings (payout ratio ~0.18). However, cash flow statements were not provided, so cash generation vs. earnings cannot be validated directly.

Leverage & Balance Sheet

Good

Total assets and equity both increased YoY (~+10%), and net debt fell sharply QoQ (~-21%), supporting balance-sheet strength.

Shareholder Returns

Strong

Strong capital appreciation (1Y +49.0%) significantly outweighs the low dividend yield (~0.15%). Buyback activity is not provided, but price momentum is a major positive.

Analyst Sentiment & Valuation

Positive

Consensus price targets ($240–$243) are slightly above the current ~$236 (modest upside). Valuation is not cheap (P/E ~29.6), implying expectations for sustained growth.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

AMETEK delivered a record Q4 with broad-based growth, strong core margin expansion, and cash generation, topping EPS guidance. Backlog and orders set records, and both groups posted double-digit sales gains, with EMG particularly strong. The company added LKC Technologies and continues to integrate 2025 acquisitions, while stepping up organic investments and launching new products. Guidance calls for high-single-digit sales growth and 6%–9% EPS growth in 2026, supported by pricing power and a robust acquisition pipeline. Management tone was confident despite macro, tax, and integration headwinds.

Growth

  • Q4 sales $2.0B, +13% y/y (organic +5%, acquisitions +7%, FX +1%)
  • Q4 orders +18% to $2.0B; organic orders +7%; record backlog $3.58B
  • Q4 operating income $523M, +12% y/y; operating margin 26.2%; core margin 27.6% (+100 bps)
  • Q4 EBITDA $618M, +10% y/y; EBITDA margin 30.9%
  • Q4 EPS $2.01, +7% y/y; above $1.90–$1.95 guidance; +11% ex prior-year tax anomaly
  • EIG Q4 sales $1.37B, +13% (organic +2%, acquisitions +10%, FX +1%); core margin 32.3% (+50 bps); op income $413.7M (+7%)
  • EMG Q4 sales $629M, +15% (organic +14%, FX +1%); op margin 22.7% (+240 bps); op income $142.5M (+28%)
  • FY25 sales $7.4B, +7%; op income $1.94B, +7%; operating margin 26.2% (+10 bps); core margins +80 bps
  • FY25 EBITDA $2.33B, +7% (margin 31.5%); EPS $7.43, +9%

Business Development

  • Announced acquisition of LKC Technologies (ophthalmic diagnostics); expands med-tech portfolio alongside Ultra Precision Technologies’ Ryker business
  • Completed 2025 acquisitions of Ferro Technologies and Kern Micro Technique for ~$1B, adding ~+$400M annual sales; integrations progressing under AMETEK Growth Model
  • Spectro launched SpectroMax and XSort elemental analysis instruments; strong demand amid rising commodity prices
  • Defense program wins in Europe: cooling solutions (Rotron, Ear Technology), high-performance computing (Abaco) for aircraft/communications, power/data systems for UAVs

Financials

  • Record Q4 free cash flow $527M (+6% y/y); FCF/NI conversion 132%
  • FY25 free cash flow $1.7B; FCF/NI conversion 113%
  • Operating working capital 16.5% of sales (βˆ’30 bps y/y)
  • Q4 G&A $33M; FY G&A 1.6% of sales; 2026E ~1.5%
  • Q4 effective tax rate 16.3% (vs 12.8%); FY25 17.8%; 2026E 18.5%–19.5%
  • Capex: Q4 $57M; FY25 $130M; 2026E ~$160M (~2% of sales)
  • 2026E depreciation & amortization ~$430M, including after-tax acquisition-related intangibles ~$210M (~$0.91/sh)

Capital & Funding

  • Year-end total debt $2.3B; cash $458M
  • Gross debt/EBITDA ~1.0x; net debt/EBITDA ~0.8x (investment-grade profile maintained)
  • Capital deployment in 2025 >$1.8B across acquisitions, buybacks, and dividends
  • Share repurchases: Q4 ~$285M; FY25 ~$443M
  • Capital capacity to deploy >$5B while maintaining investment-grade rating
  • 2026E FCF conversion 110%–115% of net income

Operations & Strategy

  • Pricing power sustained; positive price–cost spread in 2025; expected to offset inflation and known tariffs again in 2026
  • Incremental investment of ~$90M in 2025 and ~$100M planned in 2026 for R&D, engineering, sales/marketing, and digital
  • Vitality index 30% in Q4 (sales from products launched in last 3 years)
  • Portfolio focused on differentiated, mission-critical technologies in niche markets; continued core margin expansion
  • All EMG divisions grew double-digit organically in Q4; process businesses showing sequential improvement

Market & Outlook

  • 2026 sales expected up high single digits; organic growth low-to-mid single digits
  • 2026 EPS guidance $7.87–$8.07 (+6% to +9% y/y)
  • Q1 2026 sales expected ~+10% y/y; EPS $1.90–$1.95 (+6% to +9%)
  • Record backlog and improving order trends support 2026 momentum
  • Healthcare now ~21% of sales; Paragon and Rowland led Q4 low double-digit growth; FY25 high single-digit; 2026 outlook mid single-digit
  • European defense demand robust; process/analytical instrumentation pipeline strengthening; metals analysis supported by higher commodity prices

Risks Or Headwinds

  • Sluggish industrial markets and macroeconomic uncertainty
  • Inflation and tariff pressures (expected to be offset by pricing, but remain a risk)
  • Higher expected tax rate in 2026 (18.5%–19.5%) and quarterly variability
  • Acquired businesses initially lower margin; integration and margin uplift execution required
  • More challenging comps in healthcare in 2026

Sentiment: POSITIVE

Note: This summary was synthesized by AI from the AME Q4 2025 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

Loading financial data and tables...
πŸ“

SEC Filings (AME)

Β© 2026 Stock Market Info β€” AMETEK, Inc. (AME) Financial Profile